D. Kunac

发表

Identification of Priorities for Medication Safety in Neonatal Intensive Care

D. Reith, D. Kunac, Desireé L Kunac, 2005, Drug safety.

Appraising the post-marketing safety of medicines: A description of national and international pharmacovigilance with a focus on medicines used in chronic pain

Jeanette Johansson, D. Kunac, R. Savage, 2009 .

Pharmacovigilance in New Zealand

M. Harrison‐Woolrych, D. Kunac, M. Tatley, 2014 .

A new web-based Medication Error Reporting Programme (MERP) to supplement pharmacovigilance in New Zealand--findings from a pilot study in primary care.

D. Kunac, M. Seddon, M. Tatley, 2014, The New Zealand medical journal.

In‐Line Intravenous Filtration in Neonates Help not Hindrance

P. Ball, R. Broadbent, D. Kunac, 1999 .

Pharmacovigilance in New Zealand: the role of the New Zealand Pharmacovigilance Centre in facilitating safer medicines use.

M. Harrison‐Woolrych, D. Kunac, M. Tatley, 2008, The New Zealand medical journal.

Detecting Medication Errors in the New Zealand Pharmacovigilance Database

D. Kunac, M. Tatley, Desirée L. Kunac, 2011, Drug safety.

Inter- and intra-rater reliability for classification of medication related events in paediatric inpatients

N. Austin, D. Reith, S. Williams, 2006, Quality and Safety in Health Care.

Therapeutic errors captured by the New Zealand National Poisons Centre: a retrospective audit.

R. Braund, D. Kunac, Nicholas Yang, 2021, Journal of primary health care.

Incidence, Preventability, and Impact of Adverse Drug Events (ADEs) and Potential ADEs in Hospitalized Children in New Zealand

David Reith, Julia Kennedy, N. Austin, 2009, Paediatric drugs.